Lensar (LNSR) Return on Capital Employed Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -39.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.00 |
| Dec 31, 2025 | -5,957.00 |
| Sep 30, 2025 | -3,592.00 |
| Jun 30, 2025 | -1,054.00 |
| Mar 31, 2025 | -1,338.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | -486.00 |
| Jun 30, 2024 | 270.00 |
| Mar 31, 2024 | 2,199.00 |
| Dec 31, 2023 | 2,509.00 |
| Sep 30, 2023 | 2,593.00 |
| Jun 30, 2023 | 2,151.00 |
| Mar 31, 2023 | -266.00 |
| Dec 31, 2022 | -1,241.00 |
| Sep 30, 2022 | -945.00 |
| Jun 30, 2022 | -1,643.00 |
| Mar 31, 2022 | -874.00 |
| Dec 31, 2021 | -766.00 |